51759-362-22 : NDC 2026 Code

51759-362-22 : Adalimumab-ryvk ( Adalimumab-ryvk )

Additionally :

You can get information about “51759-362-22” NDC code in 51759-362-22 in HTML format

HTML | 51759-362-22 in TXT (Plain Text) format

TXT | 51759-362-22 in PDF (Portable Document Format)

PDF | 51759-362-22 in XML format

XML formats.

NDC Code : 51759-362-22 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51759-362-22",
    "PackageDescription": "2 KIT in 1 CARTON (51759-362-22)  / 1 KIT in 1 KIT *  .4 mL in 1 POUCH (65517-0002-1)  *  1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE (51759-497-31) ",
    "NDC11Code": "51759-0362-22",
    "ProductNDC": "51759-362",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Adalimumab-ryvk",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Adalimumab-ryvk",
    "DosageFormName": "KIT",
    "RouteName": null,
    "StartMarketingDate": "20250228",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761299",
    "LabelerName": "Teva Pharmaceuticals USA, Inc.",
    "SubstanceName": null,
    "StrengthNumber": null,
    "StrengthUnit": null,
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2025-06-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250228",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}